Page 181 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P0355 THE EVALUATION OF AN AUTOMATED RECALL ePOSTERS
PROGRAMME FOR SURVEILLANCE LIVER ULTRASOUND
P0356 IN PATIENTS AT INCREASED RISK OF HEPATOCELLULAR
CARCINOMA
TOP 10% Catriona Farrell*, Timothy J. Cross, Angie Halpen, Paul D. Richardson,
YI P0357 Priya Healey, Julie Barr, Nimzing Ladep, Omar Noorullah,
YI P0358 Richard P. Sturgess, Liz Boland, Nick Stern, Daniel Palmer,
YI P0359 Martin G. Lombard, Elizabeth Joekes, The United Kingdom

YI P0360 CIRCULATING FREE TUMOUR DNA CONCENTRATION
IS A MORE USEFUL DIAGNOSTIC MARKER THAN TP53
MUTATION DETECTION IN HBV-RELATED HCC IN WEST
AFRICAN PATIENTS
Susanne Knapp*, Jessica Howell,Yusuf Sherwani, Mohamed Shariff,
Lucine Karanfilian, Nimzing Ladep, Edith Okeke, Simon Taylor-
Robinson, Mark Thursz, The United Kingdom

AMINO ACID SIGNATURES IN RELATION TO THE RISK OF
HEPATOCELLULAR CARCINOMA - A PROSPECTIVE CASE-
CONTROL STUDY
Magdalena Stepien*, Talita Duarte-Salles, Veronika Fedirko,
Dinesh Kumar, Isabelle Romieu, Augustin Scalbert, Mazda Jenab, France

RISK PREDICTORS OF HEPATOCELLULAR CARCINOMA
AMONG CIRRHOTIC PATIENTS CHRONICALLY INFECTED
WITH HEPATITIS B
Justin D. Chien*, Jessica Liu, Mei-Hsuan Lee, Chin-Lan Jen,
Richard Batrla-Utermann, Sheng-Nan Lu, Li-Yu Wang, San-Lin You,
Hwai-I Yang, Chien-Jen Chen, The United States

ESM-1 IS A MARKER OF MICROVASCULAR INVASION,
SATELLITE NODULES, AND ADVERSE CLINICAL
OUTCOME IN PATIENTS WITH HEPATOCELLULAR
CARCINOMA TREATED BY SURGICAL RESECTION
Julien Calderaro*, Jean-Charles Nault, Paulette Bioulac-Sage,
Maryline Tepper, Emmanuel Sauce, Christophe Laurent,
Charlotte Costentin, Thomas Decaens, Jean-Fréderic Blanc,
Daniel Azoulay, Alain Luciani, Alexis Laurent, Nathalie Ganne-Carrié,
Marianne Ziol, France

STAT6 RS3024974 MIGHT PREDICT WORSE PROGNOSIS IN
HEPATOCELLULAR CARCINOMA PATIENTS
Yun Liao, Bei Cai,Yi Li, Lanlan Wang*, China

Vienna, Austria • April 22–26, 2015 181